Pacific Biosciences of California, Inc.
PACBNASDAQHealthcare● Active
$1.39
$-0.06(-4.21%)
Market Cap$431394684
P/E Ratio—
52W High$2.73
52W Low$0.99
Pacific Biosciences of California, Inc.（PACB）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PACB · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.16B | $0.15B | $0.20B | $0.13B | $0.13B |
| Cost of Revenue | $0.11B | $0.12B | $0.15B | $0.08B | $0.07B |
| Gross Profit | $0.05B | $0.04B | $0.05B | $0.05B | $0.06B |
| Gross Margin %(computed) | 31.67% | 24.21% | 26.32% | 38.22% | 45.10% |
| Operating Expenses | |||||
| R&D Expenses | $0.10B | $0.13B | $0.19B | $0.19B | $0.11B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.61B | $0.51B | $0.39B | $0.36B | $0.27B |
| Operating Income | ($0.56B) | ($0.47B) | ($0.33B) | ($0.31B) | ($0.21B) |
| Operating Margin %(computed) | -348.46% | -307.97% | -166.80% | -239.43% | -161.24% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Income Before Tax | ($0.55B) | ($0.31B) | ($0.32B) | ($0.31B) | ($0.27B) |
| Income Tax Expense | $0.00B | $0.00B | ($0.01B) | $0.00B | ($0.09B) |
| Net Income | ($0.55B) | ($0.31B) | ($0.31B) | ($0.31B) | ($0.18B) |
| Net Margin %(computed) | -341.47% | -201.18% | -152.97% | -244.92% | -138.85% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.82 | $-1.13 | $-1.21 | $-1.40 | $-0.89 |
| Wtd Avg Shares | 0.30B | 0.27B | 0.25B | 0.22B | 0.20B |
| EBITDA | ($0.03B) | ($0.24B) | ($0.27B) | ($0.28B) | ($0.25B) |
| EBITDA Margin %(computed) | -21.37% | -157.63% | -135.21% | -219.98% | -192.13% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Pacific Biosciences of California, Inc.
关于Pacific Biosciences of California, Inc.（PACB）损益表
Pacific Biosciences of California, Inc.（PACB）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，PACB实现营收$0.16B，毛利润$0.05B（毛利率31.67%），净利润($0.55B)（净利率-341.47%）。
常见问题
PACB · 4 问Pacific Biosciences of California, Inc.（PACB）2025财年营收为$0.16B，同比up3.9%。
PACB revenuePACB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08